Research Article

IL-37 Gene Modification Enhances the Protective Effects of Mesenchymal Stromal Cells on Intestinal Ischemia Reperfusion Injury

Figure 3

IL-37-MSCs could effectively improve intestinal barrier function following IRI. DAO and D-Lac were used to assess the gut barrier function. Serum samples were collected from the sham, IL-37-MSC-treated, MSC-treated, rIL-37-treated, and untreated IRI groups. In comparison with the MSC-treated and rIL-37-treated IRI groups, IL-37-MSCs significantly reduced serum levels of DAO and D-Lac, which meant IL-37-MSCs remarkedly improved gut barrier function. Data shown were representative, and the value was determined by one-way ANOVA followed by the LSD test. , , and .
(a)
(b)